CELEBRATING 24 YEARS IN BUSINESS OVER 300,000 CLIENTS REPRESENTED
Recent reports in the JAMA Internal Medicine indicate that patients taking Januvia are at a higher risk of developing pancreatitis when compared with those taking other Type 2 diabetic drugs which do not contain sitaglipin. The JAMA journal found that those suffering from pancreatitis who were hospitalized were twice as likely to have been taking Januvia. Januvia is an oral anti-hyperglycemic belonging to a class of drugs known as incretin mimetics which stimulate the production of insulin.
WARNING: Do not send any information in any email through this website if you consider the information confidential or privileged.
STARS ON YELP WITH OVER 400 REVIEWS*
*AS OF JANUARY 2024
TOP 10 VERDICT IN TEXAS* 2022
*BY TOPVERDICT.COM
TOP 100 NATIONAL TRIAL LAWYER* 2013-2024
*BY THE NATIONAL TRIAL LAWYERS
AVVO CLIENT'S CHOICE AWARD* 2016, 2017, 2019-2024
*GIVEN BY AVVO
AMERICAN ASSOCIATION OF JUSTICE 2013-2024
*GRANTED BY THE AAJ